Open AccessClinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma
Author(s) -
MingChu Chang,
YuTing Chang,
Jia-Yang Chen,
YungMing Jeng,
ChingYao Yang,
YuWen Tien,
ShihHung Yang,
Chen Huai-lu,
Ting-Yuan Liang,
Chien-Fang Wang,
Eva Y.-H.P. Lee,
Ying Chang,
WenHwa Lee
Publication year - 2016
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2015.248260
Subject(s) - medicine , circulating tumor cell , pancreatic ductal adenocarcinoma , oncology , clinical significance , gastroenterology , epithelial cell adhesion molecule , overall survival , pancreatic cancer , cancer , metastasis
Characterization of circulating tumor cells (CTCs) has been used to provide prognostic, predictive, and pharmacodynamic information in many different cancers. However, the clinical significance of CTCs and circulating tumor microemboli (CTM) in patients with pancreatic ductal adenocarcinoma (PDAC) has yet to be determined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom